Metabolic syndrome (MetS) is now considered as an
emerging public health issue due to increased mortality
and multiple morbidities across the globe. It can be
defined as constellation of various conditions which
can occur in combination leading to increased risk of
coronary artery diseases, stroke, diabetes mellitus (DM),
fatty liver and other adverse health conditions. Though
there is variation in diagnostic criteria decided by
different international bodies like NCEP ATP-III, IDF,
WHO; features like increased waist circumference (WC),
raised triglyceride (TG) are common component to all
criteria1,2. Each component has been revealed as an
independent risk for cardiovascular disease (CVD)
events or DM incidence but three or more combination
of factors with diagnosis of MetS increase the chance
of developing severe CVD events and DM in future.